Modulation of adenosine concentration by opioid receptor agonists in rat striatum

By Halimi G.   Devaux C.   Clot-Faybesse O.   Sampol J.   Legof L.   Rochat H.   Guieu R.  

European Journal of Pharmacology, Vol. 398, Iss. 2, 2000-06 ,pp. : 217-224

Elsevier

Access to resources Recommend Favorite

Precipitated -opioid receptor agonist withdrawal increases glutamate in rat locus coeruleus

By Hoshi K.   Ma T.   Ing K.H.  

European Journal of Pharmacology, Vol. 314, Iss. 3, 1996-10 ,pp. : 301-306

Elsevier

Access to resources Recommend Favorite

Glutamate receptor agonist injections into the dorsal striatum cause contralateral turning in the rat: involvement of kainate and AMPA receptors

By Smith I.D.   Todd M.J.   Beninger R.J.  

European Journal of Pharmacology, Vol. 301, Iss. 1, 1996-04 ,pp. : 7-17

Elsevier

Access to resources Recommend Favorite

Different effects of NMDA/group I metabotropic glutamate receptor agents in - and -opioid receptor agonist-induced supraspinal antinociception

By Suzuki T.   Aoki T.   Ohnishi O.   Nagase H.   Narita M.  

European Journal of Pharmacology, Vol. 396, Iss. 1, 2000-05 ,pp. : 23-28

Elsevier

Access to resources Recommend Favorite

SCH 58261 (an adenosine A 2A receptor antagonist) reduces, only at low doses, K + -evoked glutamate release in the striatum

By Pintor A.   Quarta D.   Pezzola A.   Reggio R.   Popoli P.  

European Journal of Pharmacology, Vol. 421, Iss. 3, 2001-06 ,pp. : 177-180

Elsevier

Access to resources Recommend Favorite